Imugene showcases Azer-Cel progress at ASCO - ICYMI

Imugene Ltd (ASX:IMU, OTC:IUGNF, FRA:ILA) earlier this week highlighted encouraging clinical progress for its Azer-Cel program after presenting new data at...